Cartel pricing dynamics with cost variability and endogenous buyer detection

By Joseph E. Harrington Jr., Joseph Chen. 2006

391 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Management Science and Operations Research, Marketing

View Paper: https://www.semanticscholar.org/paper/b07fd0f8ff1fb851e4b72765b7cdbfcf5508103d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

In Management Science and Operations Research

In Marketing

Citations in the corpus

When is Gibrat’s law a law? (2013, background): “Innovation is another determinant of rm growth that has received a lot of study (e.g., Manseld, 1962; Scherer, 1965; Mowery, 1983; Geroski & Machin, 1992; Geroski & Toker, 1992; Roper, 1997; Freel, 2000; Bottazzi et al., 2001).”
Do liquidity constraints matter in explaining firm size and growth? Some evidence from the Italian manufacturing industry (2006, methodology): “Therefore, as suggested in Bottazzi et al. (2002), we move toward a more detailed exploration of the statistical properties of the joint distribution of firms’ size and growth, conditioned on SCF and age.”
Innovation and Firm Growth: Is R&D Worth It? (2012, methodology): “Using the “super-firms” methodology, we restructured the data-set by assuming that any two (or more) firms that merged between 1950 and 2008 merged from the database’s start date and we united their firm-level data (see Bottazzi et al., 2001 for details of the “super-firms” methodology).”
Corporate growth and industrial dynamics: evidence from French manufacturing (2005, methodology): “Because of limited information on restructuring activities and in contrast to some previous studies (see Bottazzi et al. (2001) for an example), we do not attempt to construct ‘super-firms’ by treating firms that merge at some stage during the period under study as if they had been merged from the…”
Gibrat’s Law and diversification (2006, background): “the dynamics of the pharmaceutical industry is largely research-driven, so that product innovations and imitations constitute essential aspects of the growth of firms and generate an intense spreading process across different markets (Bottazzi et al., 2001).”
Invariances and Diversities in the Patterns of Industrial Evolution: Some Evidence from Italian Manufacturing Industries (2007, background): “Bottazzi et al. (2001) on the international pharmaceutical industry and Bottazzi and Secchi (2003a) on the U.”
Submarkets and the evolution of market structure (2006, background): “Bottazzi et al. [2001] also found that new submarkets driven by the discovery of new drugs help explain the evolution of the pharmaceutical industry.”
Resource constraints as triggers of radical innovation: Longitudinal evidence from the manufacturing sector (2013, background): “Prior findings from entrepreneurship and economics research unanimously suggest that firms which have discovered promising technology or market opportunities before others or which are more innovative than others in general grow significantly faster (e.g., Geroski et al., 1993; Thornhill, 2006; Very”